Estimating The Dollar Utility of Changes in Job Performance Due to Seasonal Allergic Rhinitis and its Treatment

Abstract

We developed a method for estimating the dollar utility of changes in job performance associated with illnesses and their treatments. Then we applied this method to predict, for each job in the economy, the difference in productivity costs associated with the illness of Seasonal Allergic Rhinitis (SAR) and that due to the difference between 2 commonly used treatments of SAR. The findings suggest that workers are 5% less productive when affected by SAR, and that when workers treat their SAR with desloratadine (a nonsedating antihistamine) instead of diphenhydramine (an over-the-counter 1st-generation antihistamine), they are 7% more productive, translating to a daily productivity cost differential between the 2 treatments of $11 per day, or $2.6 billion annually. The jobs most affected require high amounts of selective attention and perceptual speed (e.g., Aircraft Pilots and Flight Engineers, and those in the fields of manufacturing, security, and emergency response).